Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC ACTB-1003 939805-30-8 50mg
Supplier: Apexbio Technology LLC B490450
ACTB-1003 (CAS 939805-30-8) also known as EOC317 is an orally bioavailable small-molecule kinase inhibitor that selectively targets fibroblast growth factor receptor 1 (FGFR1) vascular endothelial growth factor receptor 2 (VEGFR2) and the endothelial-specific tyrosine kinase Tie-2 In vitro studies demonstrate that ACTB-1003 suppresses the activity of these kinases at nanomolar concentrations By modulating these angiogenesis-associated signaling pathways ACTB-1003 serves as a valuable tool for investigating tumor angiogenesis and related signal transduction mechanisms in biomedical research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?